Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidural methylprednisolone 80 mg vs 40 mg in chronic lumbar back pain
2005-006196-12Phase 4Completed
- Sponsor
- Nottingham City Hospital NHS Trust
- Start
- May 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of methylprednisolone in chronic low back pain (CLBP) and lumbodynia (LBP) (2 arms), sponsored by Nottingham City Hospital NHS Trust. Primary endpoint: Oswestry Low Back Pain Disability Index at 6 weeks. Started May 2006; status: completed.
02
Drugs
methylprednisolone
03
Conditions
chronic low back pain (CLBP)lumbodynia (LBP)
Beyond the preview
Go deeper on 2005-006196-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-006196-12.